Eros Apothecary召回Candy Power For Man有机蜂蜜一批次:含未标明他达拉非,FDA11月12日发布

美国食品药品管理局(FDA)2026年11月12日发布企业公告,加利福尼亚州印第奥的Eros Apothecary召回Candy Power For Man有机蜂蜜,原因是产品被检出含有未标明的他达拉非。
公告称,他达拉非是经FDA批准的处方药Cialis的活性成分,用于治疗勃起功能障碍,该药仅限在持牌医疗专业人员监督下使用。未标明的他达拉非可能与某些处方药中的硝酸盐(如硝酸甘油)相互作用,导致血压危险下降;糖尿病、高血压、高胆固醇或心脏病患者常服用含硝酸盐的药物。
本次召回的产品为黄色与橙色包装,一盒含60颗独立包装的糖果。包装背面标示的信息为:批次241020,生产日期2024年1月,有效期2029年12月,UPC为5285002251390。该产品于2026年4月27日至7月20日期间通过eBay销售。
公告称,本次召回是在FDA实验室检测确认未标明的他达拉非之后启动的。消费者应立即停用Candy Power For Man,并丢弃剩余产品;如出现可能与该产品有关的健康问题,应联系医疗服务提供者。
本次召回在FDA知情下进行。消费者如有疑问,可通过电邮[email protected]联系Eros Apothecary;不良反应或质量问题可通过FDA的MedWatch不良事件报告计划在线、邮寄或传真报告,电话1-800-332-1088。
Eros Apothecary Recalls One Batch of Candy Power For Man Organic Honey Over Undeclared Tadalafil — FDA Posted November 12
The U.S. Food and Drug Administration (FDA) posted a company announcement on November 12, 2026, stating that Eros Apothecary of Indio, California, is recalling Candy Power For Man Organic Honey because the product was found to contain undeclared tadalafil.
Tadalafil is the active ingredient in the FDA-approved prescription drug Cialis, used to treat erectile dysfunction, and FDA approval of Cialis is restricted to use under the supervision of a licensed health care professional, the announcement said. The undeclared tadalafil may interact with nitrates found in certain prescription medications, such as nitroglycerin, and cause a dangerous drop in blood pressure. People with diabetes, high blood pressure, high cholesterol or heart disease often take nitrate-containing medications.
The recalled product is packaged in yellow and orange packaging containing 60 individually wrapped candies. The identifying information on the back panel is batch 241020, manufacturing date January 2024, expiration date December 2029, and UPC 5285002251390. The product was sold via eBay between April 27, 2026, and July 20, 2026.
The recall was initiated after FDA laboratory testing identified the undeclared tadalafil, the announcement said. Consumers should stop using Candy Power For Man immediately and dispose of any remaining product, and consumers who have experienced health problems potentially related to the product should contact their healthcare provider.
The recall is being conducted with the knowledge of the FDA. Consumers with questions may contact Eros Apothecary at [email protected]. Adverse reactions or quality problems may be reported to the FDA's MedWatch Adverse Event Reporting program online, by regular mail or by fax; the reporting form can be requested at 1-800-332-1088.
来源:美国食品药品管理局
发布:GSM·美国(发布链接)
图片来源:FDA官方发布图(美国食品药品管理局召回公告产品图)
GSM Global · 本篇英文版 English edition of this story

